Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The caRe Study: Clinical Application of Refined Risk Estimates

NCT06534424 is registered in ClinicalTrials.gov with Ohio State University Comprehensive Cancer Center as lead sponsor.

NCT NCT06534424
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06534424 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The caRe Study: Clinical Application of Refined Risk Estimates
Lead sponsor
Ohio State University Comprehensive Cancer Center
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2018
Completion date
September 30, 2023
Enrollment
152 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

brca1/2-associated hereditary breast and ovarian cancer syndrome